Citigroup’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-35,300
Closed -$515K 5895
2023
Q1
$515K Buy
+35,300
New +$499K ﹤0.01% 3112

Citigroup's AMYT Position: Q1 2021 in Review

Citigroup sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q1 2021, closing a stake of 138 shares — an estimated $2K sold.

Citigroup first reported a position in AMYT in Q3 2020 and held it in 2 quarters. The position peaked at $2K in Q4 2020. 29 funds tracked by Wall St. Rank hold AMYT as of Q1 2021.

  • Citigroup reported no remaining Amryt Pharma plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Citigroup sold 138 Amryt Pharma plc American Depositary Shares shares in Q1 2021, an estimated $2K.
  • Citigroup first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2020 and held it in 2 quarters.
  • Citigroup's Amryt Pharma plc American Depositary Shares position peaked at $2K in Q4 2020.
  • 29 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q1 2021.

Based on Citigroup's 13F filing for Q1 2021, filed 13 May 2021.